inVentiv Health Launches Phase I Services to the U.S.
New Phase I clinical in Miami offers gateway location to Latin America.
inVentiv Health marked the official opening of its new Phase I clinic in the United States, located at the University of Miami Life Science and Technology Park. Key features of the clinic include, but are not limited to:
- 44-bed clinic to expedite progression to Proof of Concept (PoC)
- existing Phase I - Phase IV bioanalytical labs capabilities
- use of new Mytrus Enroll® eConsent technology
- gateway location to Latin America
Read the full release.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Oveporexton Shows Superior Efficacy in Phase II Narcolepsy Type 1 Trial Without Hepatotoxicity
May 16th 2025In the TAK-861-2001 Phase IIb study, oveporexton significantly improved wakefulness, daytime sleepiness, and cataplexy frequency in patients with narcolepsy type 1, outperforming current therapies and avoiding liver toxicity seen with earlier OX2R agonists, according to results published in The New England Journal of Medicine.
